See Remarks · Xeris Biopharma Holdings, Inc. · Common Stock
Side
F
Value
$823K
Shares
111.8K
Price
$7.36
Executed
Jan 31, 2026
Disclosed
Feb 2, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 31 executedFeb 2, 2026 disclosed
XERS · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+11 / 25
$823K reported value · 8.3% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Pieper Steven filed this Form 4 reporting a tax withholding of XERS on Jan 31, 2026. It became public on Feb 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
See Remarks
Pieper Stevencik:0001875714
Issuer
Xeris Biopharma Holdings, Inc.cik:0001867096
Revision history · 0
No field has changed since this record was first ingested.
